Cargando…
Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide
INTRODUCTION: Management of Lennox–Gastaut syndrome (LGS) in adulthood can be particularly challenging. Published reports describing the use of rufinamide specifically in adult patients with LGS are scarce. A post hoc subgroup analysis of data from a phase III trial was conducted to investigate the...
Autores principales: | McMurray, Rob, Striano, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919131/ https://www.ncbi.nlm.nih.gov/pubmed/26861566 http://dx.doi.org/10.1007/s40120-016-0041-9 |
Ejemplares similares
-
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
por: Balagura, Ganna, et al.
Publicado: (2020) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Stafstrom, Carl E
Publicado: (2009) -
Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy)
por: Kluger, Gerhard, et al.
Publicado: (2007) -
Novel seizure outcomes in patients with Lennox‐Gastaut syndrome: Post hoc analysis of seizure‐free days in rufinamide Study 303
por: Auvin, Stéphane, et al.
Publicado: (2019) -
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
por: Gresham, Jessica, et al.
Publicado: (2010)